NCT06809868View on ClinicalTrials.gov

Role of Transposable Elements in Septic Immune Aging

RecruitingOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

February 14, 2025

Primary Completion Date

February 14, 2026

Study Completion Date

August 14, 2026

Conditions
SepsisSepsis and Septic ShockSepsis With Multiple Organ Dysfunction (MOD)Sepsis With Acute Organ DysfunctionSepsis, SevereSepsis at Intensive Care UnitSepsis, Severe Sepsis and Septic ShockSepsis, Septic Shock
Interventions
GENETIC

RNA and DNA Sequencing

DNA and RNA sequencing will be conducted on both control participants and patients with sepsis who are admitted to the ICU.

Trial Locations (1)

94143

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER